{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:31:42Z","timestamp":1788957102971,"version":"build-2803163510"},"reference-count":89,"publisher":"Pacini Editore","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-n2222","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T06:42:11Z","timestamp":1682491331000},"page":"85-98","source":"Crossref","is-referenced-by-count":42,"title":["Nasopharyngeal carcinoma. A \u201cdifferent\u201d head and neck tumour. Part A: from histology to staging","Carcinoma rinofaringeo. Un tumore della testa e collo \u201cdiverso\u201d. Parte A: dalla istologia allo staging"],"prefix":"10.14639","volume":"43","author":[{"given":"Giulio","family":"Cant\u00f9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20340","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"10.14639\/0392-100X-N2222_ref1","unstructured":"Barnes L, Eveson JW, Reichart P, et al., editors. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005."},{"key":"10.14639\/0392-100X-N2222_ref2","unstructured":"Regaud C, Reverchon L. Sur un cas d\u2019epithelioma epidermoide develop\u00e9 dans le massif maxillaire sup\u00e9rieur, et \u00e9tendu aux t\u00e9guments de la face, aux cavit\u00e9s buccale, nasale et orbitaire, ainsi qu\u2019aux ganglions du cou. Rev Laryngol Otol Rhinol 1921;42:369."},{"key":"10.14639\/0392-100X-N2222_ref3","unstructured":"Schmincke A. Uber limpho-epitheliale geschwulste. Beitr Pathol Anat Allg Pathol 1921;68:161."},{"key":"10.14639\/0392-100X-N2222_ref4","doi-asserted-by":"crossref","unstructured":"Scanlon PW, Rhodes RE Jr, Woolner LB, et al. Cancer of the nasopharynx: 142 patients treated in the 11 year period 1950-1960. Am J Roentgenol Radium Ther Nucl Med 1967;99:313-225.","DOI":"10.2214\/ajr.99.2.313"},{"key":"10.14639\/0392-100X-N2222_ref5","unstructured":"Shanmugaratnam K, Sobin LH. Histological typing of upper respiratory tract tumours. Geneva: WHO; 1978."},{"key":"10.14639\/0392-100X-N2222_ref6","unstructured":"Shanmugaratnam K. Histological typing of nasopharyngeal carcinoma. IARC Sci Publ 1978;20:3-12."},{"key":"10.14639\/0392-100X-N2222_ref7","doi-asserted-by":"crossref","unstructured":"Shanmugaratnam K. Histological typing of tumours of the upper respiratory tract and ear. 2nd edition. Berlin: Springer-Verlag; 1991.","DOI":"10.1007\/978-3-642-84474-4"},{"key":"10.14639\/0392-100X-N2222_ref8","unstructured":"El-Naggar AK, Chan JKC, Grandis JR, et al., eds. WHO Classification of head and neck tumours. 4th edition. Lyon: IARC; 2017."},{"key":"10.14639\/0392-100X-N2222_ref9","doi-asserted-by":"crossref","unstructured":"Palazzi M, Guzzo M, Tomatis S, et al. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:1451-1458. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.05.059","DOI":"10.1016\/j.ijrobp.2004.05.059"},{"key":"10.14639\/0392-100X-N2222_ref10","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang Y, Ma S. Racial differences in nasopharyngeal carcinoma in the United States. Cancer Epidemiol 2013;37:793-802. https:\/\/doi.org\/10.1016\/j.canep.2013.08.008","DOI":"10.1016\/j.canep.2013.08.008"},{"key":"10.14639\/0392-100X-N2222_ref11","doi-asserted-by":"crossref","unstructured":"Stepan KO, Mazul AL, Skillington SA, et al. The prognostic significance of race in nasopharyngeal carcinoma by histological subtype. Head Neck 2021;43:1797-1811. https:\/\/doi.org\/10.1002\/hed.26639.","DOI":"10.1002\/hed.26639"},{"key":"10.14639\/0392-100X-N2222_ref12","doi-asserted-by":"crossref","unstructured":"Wu SG, Lian CL, Wang J, et al. The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow-up. Ann Transl Med 2019;7:768. https:\/\/doi.org\/10.21037\/atm.2019.11.75","DOI":"10.21037\/atm.2019.11.75"},{"key":"10.14639\/0392-100X-N2222_ref13","unstructured":"Batsakis JG. Tumors of the head and neck. Clinical and pathological considerations. 2nd edition. Baltimore: Williams & Wilkins; 1979."},{"key":"10.14639\/0392-100X-N2222_ref14","doi-asserted-by":"crossref","unstructured":"Buell P. Nasopharynx cancer in chinese of California. Br J Cancer 1965;19:459-470. https:\/\/doi.org\/038\/bjc.1965.54","DOI":"10.1038\/bjc.1965.54"},{"key":"10.14639\/0392-100X-N2222_ref15","doi-asserted-by":"crossref","unstructured":"Dickson RI. Nasopharyngeal carcinoma: an evaluation of 209 patients. Laryngoscope 1981;91:333-354. https:\/\/doi.org\/10.1288\/00005537-198103000-00001","DOI":"10.1288\/00005537-198103000-00001"},{"key":"10.14639\/0392-100X-N2222_ref16","doi-asserted-by":"crossref","unstructured":"Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-1777. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0353","DOI":"10.1158\/1055-9965.EPI-06-0353"},{"key":"10.14639\/0392-100X-N2222_ref17","doi-asserted-by":"crossref","unstructured":"Old LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to an antigen present in cultured Burkitt\u2019s lymphoma cells. Proc Natl Acad Sci USA 1966;56:1699-1704. https:\/\/doi.org\/10.1073\/pnas.56.6.1699","DOI":"10.1073\/pnas.56.6.1699"},{"key":"10.14639\/0392-100X-N2222_ref18","unstructured":"Henle W, Henle G. Evidence for an oncogenic potential of the Epstein-Barr virus. Cancer Res 1973;33:1419-1423."},{"key":"10.14639\/0392-100X-N2222_ref19","doi-asserted-by":"crossref","unstructured":"Klein G. The Epstein-Barr virus and neoplasia. N Engl J Med 1975;293:1353-1357. https:\/\/doi.org\/10.1056\/NEJM197512252932607","DOI":"10.1056\/NEJM197512252932607"},{"key":"10.14639\/0392-100X-N2222_ref20","doi-asserted-by":"crossref","unstructured":"Nadol JB Jr. Viral particles in nasopharyngeal carcinoma. Laryngoscope 1977;87:1932-1937. https:\/\/doi.org\/10.1002\/lary.1977.87.11.1932","DOI":"10.1002\/lary.1977.87.11.1932"},{"key":"10.14639\/0392-100X-N2222_ref21","doi-asserted-by":"crossref","unstructured":"Ziegler JL, Magrath IT, Gerber P, et al. Epstein-Barr virus and human malignancy. Ann Intern Med 1977;86:323-336. https:\/\/doi.org\/10.7326\/0003-4819-86-3-323","DOI":"10.7326\/0003-4819-86-3-323"},{"key":"10.14639\/0392-100X-N2222_ref22","doi-asserted-by":"crossref","unstructured":"Kangro HO, Osman HK, Lau YL, et al. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol 1994;43:91-96. https:\/\/doi.org\/10.1002\/jmv.1890430117","DOI":"10.1002\/jmv.1890430117"},{"key":"10.14639\/0392-100X-N2222_ref23","doi-asserted-by":"crossref","unstructured":"Dogan S, Hedberg ML, Ferris RL, et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck 2014;36:511-516. https:\/\/doi.org\/10.1002\/hed.23318","DOI":"10.1002\/hed.23318"},{"key":"10.14639\/0392-100X-N2222_ref24","doi-asserted-by":"crossref","unstructured":"Verma V, Simone CB 2nd, Lin C. Human papillomavirus and nasopharyngeal cancer. Head Neck 2018;40:696-706. https:\/\/doi.org\/10.1002\/hed.24978","DOI":"10.1002\/hed.24978"},{"key":"10.14639\/0392-100X-N2222_ref25","doi-asserted-by":"crossref","unstructured":"Wu SS, Chen B, Fleming CW, et al. Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution. Head Neck 2022;44:851-861. https:\/\/doi.org\/10.1002\/hed.26976","DOI":"10.1002\/hed.26976"},{"key":"10.14639\/0392-100X-N2222_ref26","doi-asserted-by":"crossref","unstructured":"Yu MC, Nichols PW, Zou XN, et al. Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish. Br J Cancer 1989;60:198-201. https:\/\/doi.org\/10.1038\/bjc.1989.250","DOI":"10.1038\/bjc.1989.250"},{"key":"10.14639\/0392-100X-N2222_ref27","doi-asserted-by":"crossref","unstructured":"Zheng X, Luo Y, Christensson B, et al. Induction of nasal and nasopharyngeal tumours in Sprague-Dawley rats fed with Chinese salted fish. Acta Otolaryngol 1994;114:98-104. https:\/\/doi.org\/10.3109\/00016489409126024","DOI":"10.3109\/00016489409126024"},{"key":"10.14639\/0392-100X-N2222_ref28","doi-asserted-by":"crossref","unstructured":"Zou XN, Lu SH, Liu B. Volatile N-nitrosamines and their precursors in Chinese salted fish \u2013 a possible etiological factor for NPC in china. Int J Cancer 1994;59:155-158. https:\/\/doi.org\/10.1002\/ijc.2910590202","DOI":"10.1002\/ijc.2910590202"},{"key":"10.14639\/0392-100X-N2222_ref29","doi-asserted-by":"crossref","unstructured":"Lin C, Cao SM, Chang ET, et al. Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: a population-based case-control study. Cancer 2019;125:4462-4470. https:\/\/doi.org\/10.1002\/cncr.32458","DOI":"10.1002\/cncr.32458"},{"key":"10.14639\/0392-100X-N2222_ref30","doi-asserted-by":"crossref","unstructured":"Roy Chattopadhyay N, Das P, Chatterjee K, Choudhuri T. Higher incidence of nasopharyngeal carcinoma in some regions in the world confers for interplay between genetic factors and external stimuli. Drug Discov Ther 2017;11:170-180. https:\/\/doi.org\/10.5582\/ddt.2017.01030","DOI":"10.5582\/ddt.2017.01030"},{"key":"10.14639\/0392-100X-N2222_ref31","doi-asserted-by":"crossref","unstructured":"Casanova M, Bisogno G, Gandola L, et al. Rare tumors in pediatric age group. A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project. Cancer 2012;118:2718-2725. https:\/\/doi.org\/10.1002\/cncr.26528","DOI":"10.1002\/cncr.26528"},{"key":"10.14639\/0392-100X-N2222_ref32","doi-asserted-by":"crossref","unstructured":"Sultan I, Casanova M, Ferrari A, et al. Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr Blood Cancer 2010;55:279-284. https:\/\/doi.org\/10.1002\/pbc.22521","DOI":"10.1002\/pbc.22521"},{"key":"10.14639\/0392-100X-N2222_ref33","doi-asserted-by":"crossref","unstructured":"Lee AW, Foo W, Mang O, et al. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality. Int J Cancer 2003;103:680-685. https:\/\/doi.org\/10.1002\/ijc.10894","DOI":"10.1002\/ijc.10894"},{"key":"10.14639\/0392-100X-N2222_ref34","doi-asserted-by":"crossref","unstructured":"Mudry A. Pharyngeal recess or Rosenm\u00fcller\u2019s fossa: its first description revisited. Head Neck 2021;43:2295-2296. https:\/\/doi.org\/10.1002\/hed.26766","DOI":"10.1002\/hed.26766"},{"key":"10.14639\/0392-100X-N2222_ref35","doi-asserted-by":"crossref","unstructured":"Chong VF, Fan YF, Khoo JB. Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J Comput Assist Tomogr 1996;20:563-569. https:\/\/doi.org\/10.1097\/00004728-199607000-00012","DOI":"10.1097\/00004728-199607000-00012"},{"key":"10.14639\/0392-100X-N2222_ref36","doi-asserted-by":"crossref","unstructured":"Pak MW, To KF, Lo YM, et al. Nasopharyngeal carcinoma in situ (NPCIS) \u2013 pathologic and clinical perspectives. Head Neck 2002;24:989-995. https:\/\/doi.org\/10.1002\/hed.10161","DOI":"10.1002\/hed.10161"},{"key":"10.14639\/0392-100X-N2222_ref37","unstructured":"Lee AW, Foo W, Law SC, et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J 1997;3:355-361."},{"key":"10.14639\/0392-100X-N2222_ref38","doi-asserted-by":"crossref","unstructured":"Lederman M. Cancer Of The nasopharynx. Proc R Soc Med 1964;57:740-742.","DOI":"10.1177\/003591576405700830"},{"key":"10.14639\/0392-100X-N2222_ref39","doi-asserted-by":"crossref","unstructured":"Wang KH, Austin SA, Chen SH, et al. Nasopharyngeal carcinoma diagnostic challenge in a nonendemic setting: our experience with 101 patients. Perm J 2017;21:16-180. https:\/\/doi.org\/10.7812\/TPP\/16-180","DOI":"10.7812\/TPP\/16-180"},{"key":"10.14639\/0392-100X-N2222_ref40","doi-asserted-by":"crossref","unstructured":"Glynn F, Keogh IJ, Ali TA, et al. Routine nasopharyngeal biopsy in adults presenting with isolated serous otitis media: is it justified? J Laryngol Otol 2006;120:439-441. https:\/\/doi.org\/10.1017\/S0022215106000685","DOI":"10.1017\/S0022215106000685"},{"key":"10.14639\/0392-100X-N2222_ref41","doi-asserted-by":"crossref","unstructured":"Finkelstein Y, Ophir D, Talmi YP, et al. Adult-onset otitis media with effusion. Arch Otolaryngol Head Neck Surg 1994;120:517-527. https:\/\/doi.org\/10.1001\/archotol.1994.01880290029006","DOI":"10.1001\/archotol.1994.01880290029006"},{"key":"10.14639\/0392-100X-N2222_ref42","doi-asserted-by":"crossref","unstructured":"Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-1449. https:\/\/doi.org\/10.1002\/1097-0142(197206)29:6<1446::aid-cncr2820290604>3.0.co;2-c","DOI":"10.1002\/1097-0142(197206)29:6<1446::AID-CNCR2820290604>3.0.CO;2-C"},{"key":"10.14639\/0392-100X-N2222_ref43","doi-asserted-by":"crossref","unstructured":"Molinari R, Cant\u00f9 G, Chiesa F, et al A statistical approach to detection of the primary cancer based on the site of neck lymph node metastases. Tumori 1977;63:267-282.","DOI":"10.1177\/030089167706300305"},{"key":"10.14639\/0392-100X-N2222_ref44","doi-asserted-by":"crossref","unstructured":"Robbins KT, Medina JE, Wolfe GT, et al. Standardizing neck dissection terminology. Official report of the Academy\u2019s Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601-605. https:\/\/doi.org\/10.1001\/archotol.1991.01870180037007.a","DOI":"10.1001\/archotol.1991.01870180037007"},{"key":"10.14639\/0392-100X-N2222_ref45","doi-asserted-by":"crossref","unstructured":"Ho FC, Tham IW, Earnest A, et al. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer 2012;12:98. https:\/\/doi.org\/10.1186\/1471-2407-12-98","DOI":"10.1186\/1471-2407-12-98"},{"key":"10.14639\/0392-100X-N2222_ref46","doi-asserted-by":"crossref","unstructured":"Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol 2015;33:3269-3276. https:\/\/doi.org\/10.1200\/JCO.2015.61.2929","DOI":"10.1200\/JCO.2015.61.2929"},{"key":"10.14639\/0392-100X-N2222_ref47","doi-asserted-by":"crossref","unstructured":"Jia S, Wang Y, He H, et al. Incidence of level IIB lymph node metastasis in supraglottic laryngeal squamous cell carcinoma with clinically negative neck \u2013 a prospective study. Head Neck 2013;35:987-991. https:\/\/doi.org\/10.1002\/hed.23062","DOI":"10.1002\/hed.23062"},{"key":"10.14639\/0392-100X-N2222_ref48","doi-asserted-by":"crossref","unstructured":"Sakai A, Okami K, Sugimoto R, et al. Evaluating the significance of level IIb neck dissection for hypopharyngeal cancer. Head Neck 2013;35:1777-1780. https:\/\/doi.org\/10.1002\/hed.23236","DOI":"10.1002\/hed.23236"},{"key":"10.14639\/0392-100X-N2222_ref49","doi-asserted-by":"crossref","unstructured":"Gr\u00e9goire V, Ang K, Budach W, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol 2014;110:172-181. https:\/\/doi.org\/0.1016\/j.radonc.2013.10.010","DOI":"10.1016\/j.radonc.2013.10.010"},{"key":"10.14639\/0392-100X-N2222_ref50","doi-asserted-by":"crossref","unstructured":"Wang X, Hu C, Ying H, et al. Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels. Radiother Oncol 2015;115:41-45. https:\/\/doi.org\/10.1016\/j.radonc.2015.02.017","DOI":"10.1016\/j.radonc.2015.02.017"},{"key":"10.14639\/0392-100X-N2222_ref51","doi-asserted-by":"crossref","unstructured":"Jiang C, Gong B, Gao H, et al. Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC). Radiother Oncol 2021;161:23-28. https:\/\/doi.org\/10.1016\/j.radonc.2021.05.020","DOI":"10.1016\/j.radonc.2021.05.020"},{"key":"10.14639\/0392-100X-N2222_ref52","doi-asserted-by":"crossref","unstructured":"Zhang GY, Liu LZ, Wei WH, et al. Radiologic criteria of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma treated with radiation therapy. Radiology 2010;255:605-612. https:\/\/doi.org\/10.1148\/radiol.10090289","DOI":"10.1148\/radiol.10090289"},{"key":"10.14639\/0392-100X-N2222_ref53","doi-asserted-by":"crossref","unstructured":"Pan XB, Huang ST, Qu S, et al. Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma. PLoS One 2021;16:e0253424. https:\/\/doi.org\/10.1371\/journal.pone.0253424","DOI":"10.1371\/journal.pone.0253424"},{"key":"10.14639\/0392-100X-N2222_ref54","unstructured":"Huang CJ, Leung SW, Lian SL, et al. Patterns of distant metastases in nasopharyngeal carcinoma. Kaohsiung J Med Sci 1996;12:229-234."},{"key":"10.14639\/0392-100X-N2222_ref55","doi-asserted-by":"crossref","unstructured":"Qu W, Li S, Zhang M, et al. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: a large-population retrospective analysis. Cancer Med 2020;9:6147-6158. https:\/\/doi.org\/10.1002\/cam4.3301","DOI":"10.1002\/cam4.3301"},{"key":"10.14639\/0392-100X-N2222_ref56","doi-asserted-by":"crossref","unstructured":"Bossi P, Chan AT, Licitra L, et al; ESMO Guidelines Committee. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol 2021;32:452-465. https:\/\/doi.org\/10.1016\/j.annonc.2020.12.007","DOI":"10.1016\/j.annonc.2020.12.007"},{"key":"10.14639\/0392-100X-N2222_ref57","doi-asserted-by":"crossref","unstructured":"Abdel Khalek Abdel Razek A, King A. MRI and CT of nasopharyngeal carcinoma. AJR Am J Roentgenol 2012;198:11-8. https:\/\/doi.org\/10.2214\/AJR.11.6954","DOI":"10.2214\/AJR.11.6954"},{"key":"10.14639\/0392-100X-N2222_ref58","doi-asserted-by":"crossref","unstructured":"Chen J, Luo J, He X, et al. Evaluation of Contrast-Enhanced Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) in the detection of retropharyngeal lymph node metastases in nasopharyngeal carcinoma patients. Cancer Manag Res 2020;12:1733-1739. https:\/\/doi.org\/10.2147\/CMAR.S244034","DOI":"10.2147\/CMAR.S244034"},{"key":"10.14639\/0392-100X-N2222_ref59","doi-asserted-by":"crossref","unstructured":"King AD, Vlantis AC, Bhatia KS, et al. Primary nasopharyngeal carcinoma: diagnostic accuracy of MR imaging versus that of endoscopy and endoscopic biopsy. Radiology 2011;258:531-537. https:\/\/doi.org\/10.1148\/radiol.10101241","DOI":"10.1148\/radiol.10101241"},{"key":"10.14639\/0392-100X-N2222_ref60","doi-asserted-by":"crossref","unstructured":"King AD, Vlantis AC, Yuen TW, et al. Detection of nasopharyngeal carcinoma by MR imaging: diagnostic accuracy of MRI compared with endoscopy and endoscopic biopsy based on long-term follow-up. AJNR Am J Neuroradiol 2015;36:2380-2385. https:\/\/doi.org\/10.3174\/ajnr.A4456","DOI":"10.3174\/ajnr.A4456"},{"key":"10.14639\/0392-100X-N2222_ref61","doi-asserted-by":"crossref","unstructured":"Xu C, Zhang Y, Peng L, et al. Optimal modality for detecting distant metastasis in primary nasopharyngeal carcinoma during initial staging: a systemic review and meta-analysis of 1774 patients. J Cancer 2017;8:1238-1248. https:\/\/doi.org\/10.7150\/jca.18361","DOI":"10.7150\/jca.18361"},{"key":"10.14639\/0392-100X-N2222_ref62","doi-asserted-by":"crossref","unstructured":"Ng SH, Chan SC, Yen TC, et al. Staging of untreated nasopharyngeal carcinoma with PET\/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging 2009;36:12-22. https:\/\/doi.org\/10.1007\/s00259-008-0918-7","DOI":"10.1007\/s00259-008-0918-7"},{"key":"10.14639\/0392-100X-N2222_ref63","unstructured":"National Comprehensive Cancer Network. Head and Neck Cancers (Version 3.2021) (http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bone.pdf, accessed April 27, 2021)."},{"key":"10.14639\/0392-100X-N2222_ref64","doi-asserted-by":"crossref","unstructured":"Macdonald MR, Freeman JL, Hui MF, et al. Role of Epstein-Barr virus in fine-needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma. Head Neck 1995;17:487-493. https:\/\/doi.org\/10.1002\/hed.2880170606","DOI":"10.1002\/hed.2880170606"},{"key":"10.14639\/0392-100X-N2222_ref65","doi-asserted-by":"crossref","unstructured":"Lee WY, Hsiao JR, Jin YT, et al. Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck 2000;22:336-340. https:\/\/doi.org\/10.1002\/1097-0347(200007)22:4<336::aid-hed4>3.0.co;2-t.","DOI":"10.1002\/1097-0347(200007)22:4<336::AID-HED4>3.0.CO;2-T"},{"key":"10.14639\/0392-100X-N2222_ref66","unstructured":"Lo YM, Leung SF, Chan LY, et al. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 2000;60:2351-2355."},{"key":"10.14639\/0392-100X-N2222_ref67","unstructured":"To EW, Chan KC, Leung SF, et al. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res 2003;9:3254-3259."},{"key":"10.14639\/0392-100X-N2222_ref68","doi-asserted-by":"crossref","unstructured":"Chan KCA, Woo JKS, King A, et al. Analysis of plasma epstein-barr virus dna to screen for nasopharyngeal cancer. N Engl J Med 2017;377:513-522. https:\/\/doi.org\/10.1056\/NEJMoa1701717","DOI":"10.1056\/NEJMoa1701717"},{"key":"10.14639\/0392-100X-N2222_ref69","doi-asserted-by":"crossref","unstructured":"Harris JP, Saraswathula A, Kaplun B, et al. Cost-effectiveness of screening for nasopharyngeal carcinoma among Asian American Men in the United States. Otolaryngol Head Neck Surg 2019;161:82-90. https:\/\/doi.org\/10.1177\/0194599819832593]","DOI":"10.1177\/0194599819832593"},{"key":"10.14639\/0392-100X-N2222_ref70","doi-asserted-by":"crossref","unstructured":"Gono K, Yamazaki K, Doguchi N, et al. Endoscopic observation of tissue by narrowband illumination. OPT REV 2003;10:211-215. https:\/\/doi.org\/10.1007\/s10043-003-0211-8","DOI":"10.1007\/s10043-003-0211-8"},{"key":"10.14639\/0392-100X-N2222_ref71","unstructured":"Piazza C, Dessouky O, Peretti G, et al. Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas. Review of the literature. Acta Otorhinolaryngol Ital 2008;28:49-54."},{"key":"10.14639\/0392-100X-N2222_ref72","doi-asserted-by":"crossref","unstructured":"Yeung DC, Vlantis AC, Wong EW, et al. A meta-analysis of narrow-band imaging for the diagnosis of primary nasopharyngeal carcinoma. F1000Res 2018;7:759. https:\/\/doi.org\/10.12688\/f1000research.15183.1","DOI":"10.12688\/f1000research.15183.1"},{"key":"10.14639\/0392-100X-N2222_ref73","doi-asserted-by":"crossref","unstructured":"Wen YH, Zhu XL, Lei WB, et al. Narrow-band imaging: a novel screening tool for early nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2012;138:183-188. https:\/\/doi.org\/10.1001\/archoto.2011.1111","DOI":"10.1001\/archoto.2011.1111"},{"key":"10.14639\/0392-100X-N2222_ref74","doi-asserted-by":"crossref","unstructured":"Yang H, Zheng Y, Chen Q, et al. The diagnostic value of narrow-band imaging for the detection of nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec 2012;74:235-239. https:\/\/doi.org\/10.1159\/000342277","DOI":"10.1159\/000342277"},{"key":"10.14639\/0392-100X-N2222_ref75","doi-asserted-by":"crossref","unstructured":"Vlantis AC, Woo JK, Tong MC, et al. Narrow band imaging endoscopy of the nasopharynx is not more useful than white light endoscopy for suspected nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2016;273:3363-3369. https:\/\/doi.org\/10.1007\/s00405-016-3940-6","DOI":"10.1007\/s00405-016-3940-6"},{"key":"10.14639\/0392-100X-N2222_ref76","doi-asserted-by":"crossref","unstructured":"Vlantis AC, Wong EWY, Ng SK, et al. Narrow band imaging endoscopy of the nasopharynx for malignancy: an inter- and intraobserver study. Laryngoscope 2019;129:1374-1379. https:\/\/doi.org\/10.1002\/lary.27483","DOI":"10.1002\/lary.27483"},{"key":"10.14639\/0392-100X-N2222_ref77","doi-asserted-by":"crossref","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441-446. https:\/\/doi.org\/10.1016\/j.ejca.2011.11.036","DOI":"10.1016\/j.ejca.2011.11.036"},{"key":"10.14639\/0392-100X-N2222_ref78","doi-asserted-by":"crossref","unstructured":"Li S, Deng YQ, Zhu ZL, et al. A comprehensive review on radiomics and deep learning for nasopharyngeal carcinoma imaging. Diagnostics (Basel) 2021;11:1523. https:\/\/doi.org\/10.3390\/diagnostics11091523","DOI":"10.3390\/diagnostics11091523"},{"key":"10.14639\/0392-100X-N2222_ref79","doi-asserted-by":"crossref","unstructured":"Scapicchio C, Gabelloni M, Barucci A, et al. A deep look into radiomics. Radiol Med 2021;126:1296-1311. https:\/\/doi.org\/10.1007\/s11547-021-01389-x","DOI":"10.1007\/s11547-021-01389-x"},{"key":"10.14639\/0392-100X-N2222_ref80","doi-asserted-by":"crossref","unstructured":"Park JE, Kim D, Kim HS, et al. Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement. Eur Radiol 2020;30:523-536. https:\/\/doi.org\/10.1007\/s00330-019-06360-z","DOI":"10.1007\/s00330-019-06360-z"},{"key":"10.14639\/0392-100X-N2222_ref81","doi-asserted-by":"crossref","unstructured":"Gao Y, Mao Y, Lu S, et al. Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma. Head Neck 2021;43:3730-3742. https:\/\/doi.org\/10.1002\/hed.26867","DOI":"10.1002\/hed.26867"},{"key":"10.14639\/0392-100X-N2222_ref82","doi-asserted-by":"crossref","unstructured":"Spadarella G, Calareso G, Garanzini E, et al. MRI based radiomics in nasopharyngeal cancer: Systematic review and perspectives using radiomic quality score (RQS) assessment. Eur J Radiol 2021;140:109744. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109744","DOI":"10.1016\/j.ejrad.2021.109744"},{"key":"10.14639\/0392-100X-N2222_ref83","doi-asserted-by":"crossref","unstructured":"Lee AW, Foo W, Law SC, et al. Staging of nasopharyngeal carcinoma: from Ho\u2019s to the new UICC system. Int J Cancer 1999;84:179-187. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19990420)84:2<179::aid-ijc15>3.0.co;2-6","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6"},{"key":"10.14639\/0392-100X-N2222_ref84","doi-asserted-by":"crossref","unstructured":"Zong J, Huang Q, Guo Q, et al. Evolution of the Chinese staging system for nasopharyngeal carcinoma. Chin Clin Oncol 2016;5:19. https:\/\/doi.org\/10.21037\/cco.2016.03.04","DOI":"10.21037\/cco.2016.03.04"},{"key":"10.14639\/0392-100X-N2222_ref85","doi-asserted-by":"crossref","unstructured":"Grandi C, Boracchi P, Mezzanotte G, et al. Analysis of prognostic factors and proposal of a new classification for nasopharyngeal cancer. Head Neck 1990;12:31-40. https:\/\/doi.org\/10.1002\/hed.2880120105","DOI":"10.1002\/hed.2880120105"},{"key":"10.14639\/0392-100X-N2222_ref86","doi-asserted-by":"crossref","unstructured":"Teo PM, Leung SF, Yu P, et al. A comparison of Ho\u2019s, International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma. Cancer 1991;67:434-439. https:\/\/doi.org\/10.1002\/1097-0142(19910115)67:2<434::aid-cncr2820670219>3.0.co;2-a","DOI":"10.1002\/1097-0142(19910115)67:2<434::AID-CNCR2820670219>3.0.CO;2-A"},{"key":"10.14639\/0392-100X-N2222_ref87","doi-asserted-by":"crossref","unstructured":"Pan J, Xu Y, Qiu S, et al. A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma. Am J Clin Oncol 2015;38:189-196. https:\/\/doi.org\/10.1097\/COC.0b013e31828f5c96","DOI":"10.1097\/COC.0b013e31828f5c96"},{"key":"10.14639\/0392-100X-N2222_ref88","doi-asserted-by":"crossref","unstructured":"Ma BB, King A, Lo YM, et al. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;66:714-720. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.05.064","DOI":"10.1016\/j.ijrobp.2006.05.064"},{"key":"10.14639\/0392-100X-N2222_ref89","doi-asserted-by":"crossref","unstructured":"Guo R, Tang LL, Mao YP, et al. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. Cancer 2019;125:79-89. https:\/\/doi.org\/10.1002\/cncr.31741","DOI":"10.1002\/cncr.31741"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/2222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T03:21:12Z","timestamp":1729653672000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/2222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":89,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-n2222","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"article-number":"1"}}